111 related articles for article (PubMed ID: 494170)
1. Effects of proteolytic degradation products of human fibrinogen and of human factor VIII on platelet aggregation and vascular permeability.
Stachurska J; Lopaciuk S; Gerdin B; Saldeen T; Korościk A; Kopeć M
Thromb Res; 1979; 15(5-6):663-72. PubMed ID: 494170
[No Abstract] [Full Text] [Related]
2. Biological effects of fibrinogen-fibrin degradation products.
Larrieu MJ; Dray L; Ardaillou N
Thromb Diath Haemorrh; 1975 Dec; 34(3):686-92. PubMed ID: 1108283
[No Abstract] [Full Text] [Related]
3. Factor VIII and human platelet aggregation. IV. Effect of proteolytic enzymes on platelet aggregation by factor VIII.
Vermylen J; Bottecchia D
Br J Haematol; 1976 Oct; 34(2):331-40. PubMed ID: 135576
[TBL] [Abstract][Full Text] [Related]
4. The influence of drugs on disseminated intravascular coagulation (DIC). IV. Effects on the thrombin-like enzyme batroxobin on thrombin-induced DIC in rats.
Markwardt F; Nowak G
Thromb Res; 1980 Jan 1-15; 17(1-2):103-11. PubMed ID: 6990544
[No Abstract] [Full Text] [Related]
5. The stimulatory capacity of soluble fibrin prepared from high and low molecular weight fibrinogen on plasminogen activation.
Halvorsen S; Skjønsberg OH; Godal HC
Blood Coagul Fibrinolysis; 1993 Feb; 4(1):133-7. PubMed ID: 8457641
[TBL] [Abstract][Full Text] [Related]
6. [Effect of fibrin degradation products on different biological tests (author's transl)].
Vila V; Aznar J; Regañon E
Sangre (Barc); 1976; 21(4):814-26. PubMed ID: 1006498
[No Abstract] [Full Text] [Related]
7. Suppressive effect of low molecular weight fibrinogen degradation products on human and rat lymphocytes.
Krzystyniak K; Stachurska J; Ryzewski J; Bykowska K; Kopeć M
Thromb Res; 1978 Mar; 12(3):523-30. PubMed ID: 653639
[No Abstract] [Full Text] [Related]
8. Vasoactive peptides derived from degradation of fibrinogen and fibrin.
Saldeen T
Ann N Y Acad Sci; 1983 Jun; 408():424-37. PubMed ID: 6575698
[No Abstract] [Full Text] [Related]
9. Permeability enhancing and chemotactic activities of lower molecular weight degradation products of human fibrinogen.
Sueishi K; Nanno S; Tanaka K
Thromb Haemost; 1981 Feb; 45(1):90-4. PubMed ID: 7245130
[TBL] [Abstract][Full Text] [Related]
10. Effect of fibrin degradation products on microvascular permeability.
Gerdin B; Saldeen T
Thromb Res; 1978 Dec; 13(6):995-1006. PubMed ID: 749269
[No Abstract] [Full Text] [Related]
11. Thrombin-induced conversion of fibrinogen to fibrin results in rapid platelet trapping which is not dependent on platelet activation or GPIb.
Jarvis GE; Atkinson BT; Frampton J; Watson SP
Br J Pharmacol; 2003 Feb; 138(4):574-83. PubMed ID: 12598411
[TBL] [Abstract][Full Text] [Related]
12. Factor VIII and human platelet aggregation. II. Characteristics of aggregation of human platelets by bovine factor VIII.
Bottecchia D; Vermylen J
Br J Haematol; 1976 Oct; 34(2):313-20. PubMed ID: 987797
[TBL] [Abstract][Full Text] [Related]
13. [Effect of fibronectin on fibrinogen conversion into fibrin].
Litvinov RI; Zubairov DM
Biokhimiia; 1988 Jul; 53(7):1203-13. PubMed ID: 3179367
[TBL] [Abstract][Full Text] [Related]
14. Activated thrombin-activatable fibrinolysis inhibitor attenuates spontaneous fibrinolysis of batroxobin-induced fibrin deposition in rat lungs.
Wu C; Dong N; da Cunha V; Martin-McNulty B; Tran K; Nagashima M; Wu Q; Morser J; Wang YX
Thromb Haemost; 2003 Sep; 90(3):414-21. PubMed ID: 12958609
[TBL] [Abstract][Full Text] [Related]
15. Effect of fibrin degradation products and thrombin on fibrinogen synthesis.
Ittyerah TR; Weidner N; Wochner RD; Sherman LA
Br J Haematol; 1979 Dec; 43(4):661-8. PubMed ID: 526446
[TBL] [Abstract][Full Text] [Related]
16. Fragment E derived from both fibrin and fibrinogen stimulates interleukin-6 production in rat peritoneal macrophages.
Lee ME; Rhee KJ; Nham SU
Mol Cells; 1999 Feb; 9(1):7-13. PubMed ID: 10102564
[TBL] [Abstract][Full Text] [Related]
17. Fibrinogen Petoskey: identification of a new dysfibrinogenemia characterized by altered release of fibrinopeptide A.
Higgins DL; Penner JA; Shafer JA
Thromb Res; 1981 Sep; 23(6):491-504. PubMed ID: 6459662
[No Abstract] [Full Text] [Related]
18. The influence of thrombin on the platelet-aggregating activity of human factor VIII. A study with insolubilized thrombin.
Vukovich T; Koller E; Doleschel W
Thromb Haemost; 1979 Oct; 42(3):832-7. PubMed ID: 505400
[TBL] [Abstract][Full Text] [Related]
19. Properties of fibrinogen cleaved by Jararhagin, a metalloproteinase from the venom of Bothrops jararaca.
Kamiguti AS; Slupsky JR; Zuzel M; Hay CR
Thromb Haemost; 1994 Aug; 72(2):244-9. PubMed ID: 7831660
[TBL] [Abstract][Full Text] [Related]
20. Influence of fibrin, fibrinogen and fibrinogen degradation products on cultured endothelial cells.
Watanabe K; Tanaka K
Atherosclerosis; 1983 Jul; 48(1):57-70. PubMed ID: 6882509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
